Summary
Zimbabwe is one of the first countries to introduce a new HIV prevention drug called lenacapavir. The drug, which needs only two injections a year, aims to reduce new infections in high-risk groups. It's being provided for free in Zimbabwe with support from international health organizations.
Key Facts
- Zimbabwe launched a long-acting HIV prevention drug called lenacapavir.
- The drug requires injections just twice a year.
- Lenacapavir aims to help high-risk groups like sex workers and young women.
- It is part of a broader rollout supported by international donors like PEPFAR and the Global Fund.
- The drug is offered for free in Zimbabwe.
- Lenacapavir's longer duration and discretion give it advantages over daily pills.
- The drug has also been introduced in countries such as Zambia and Eswatini.
- Zimbabwe has made significant progress in HIV control but new infections remain a concern.
